[1]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384-388,393.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
　Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):384-388,393.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
点击复制

质子重离子治疗肿瘤的进展(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
40
期数:
2016年第5期
页码:
384-388,393
栏目:
综述
出版日期:
2016-09-25

文章信息/Info

Title:
Development of proton heavy ion in tumor therapy
作者:
赵徵鑫;  翟贺争;  张文艺;  焦玲
300192 天津, 中国医学科学院北京协和医学院放射医学研究所, 天津市放射医学与分子核医学重点实验室
Author(s):
Zhao Zhixin;  Zhai Hezheng;  Zhang Wenyi;  Jiao Ling
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Tianjin 300192, China
关键词:
质子; 重离子; 放射疗法; 肿瘤
Keywords:
Protons; Heavy ions; Radiotherapy; Neoplasms
DOI:
10.3760/cma.j.issn.1673-4114.2016.05.010
摘要:
对于恶性肿瘤而言，传统的治疗手段主要包括手术、化疗、常规放疗等。尽管这些治疗手段在肿瘤治疗方面发挥了重要作用，但也存在很大的不足，有的治疗效果不佳，有的存在严重的并发症。为了解决上述治疗手段在肿瘤治疗方面存在的问题，国内外研究者成功研发出新的治疗手段——质子重离子放疗。笔者对此种治疗手段的基本原理和临床应用效果进行详细的介绍，以便为肿瘤科医师和患者在治疗过程中提供更多的信息和决策支持。
Abstract:
For malignant tumor, the traditional treatments mainly include surgery, chemotherapy, conventional radiotherapy, etc. Although these treatments play an important role in tumor therapy, however, there are still significant deficiencies:some clinical treatment ineffective, and some serious complications. In order to solve these problems which caused by the above treatment in tumor therapy, domestic and foreign researchers have successfully developed a new treatment-proton heavy ion radiotherapy. The author makes a detailed introduction to the basic principles and clinical application of this treatment method, and provide more information and support for cancer patients and oncologist.

参考文献/References:

[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66(2):115-132.DOI:10.3322/caac.21338.
[2] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2016[J].CA Cancer J Clin, 2016, 66(1):7-30.DOI:10.3322/caac.21332.
[3] Torre LA, Bray F, Siegel RL, et al.Global cancer statistics, 2012[J].CA Cancer J Clin, 2015, 65(2):87-108.DOI:10.3322/caac.21262.
[4] Yock TI, Caruso PA.Risk of second cancers after photon and proton radiotherapy:a review of the data[J].Health Phys, 2012, 103(5):577-585.DOI:10.1097/HP.0b013e3182609ba4.
[5] Hamada N, Imaoka T, Masunaga S, et al.Recent advances in the biology of heavy-ion cancer therapy[J].J Radiat Res, 2010, 51(4):365-383.DOI:10.1269/jrr.09137.
[6] Schipler A, Iliakis G.DNA double-strand-break complexity levels and their possible contributions to the probability for error-prone processing and repair pathway choice[J].Nucleic Acids Res, 2013, 41(16):7589-7605.DOI:10.1093/nar/gkt556.郭传玲, 王菊芳, 魏巍, 等.高LET重离子照射人肿瘤细胞的DNA双链断裂及修复研究[J].核技术, 2007, 30(9):750-753.DOI:10.3321/j.issn:0253-3219.2007.09.007.
[7] Guo CL, Wang JF, Wei W, et al.DNA double Strand break and repair of human tumor cells irradiated by high LET heavy ions[J].Nucl Tech, 2007, 30(9):750-753.
[8] Averbeck NB, Topsch J, Scholz MA, et al.Efficient rejoining of DNA double-strand breaks despite increased cell-Killing effectiveness following spread-out bragg peak carbon-ion irradiation[J].Front Oncol, 2016, 6(28):1-8.DOI:10.3389/fonc.2016.00028.
[9] Kanai T, Furusawa Y, Fukutsu K, et al.Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy[J].Radiat Res, 1997, 147(1):78-85.DOI:10.2307/3579446.
[10] Tsujii H, Kamada T.A review of update clinical results of Carbon ion radiotherapy[J].Jpn J Clin Oncol, 2012, 42(8):670-685.DOI:10.1093/jjco/hys104.
[11] Sisterson JM.Clinical use of protons and ion beams from a word-wide perspective[J].Nucl Instrum Meth Biol, 1989, 40(41):1350-1352.DOI:10.1016/0168-583X(89)90654-X.
[12] Ando K, Kase Y.Biological characteristics of carbon-ion therapy[J].Int J Radiat Biol, 2009, 85(9):715-728.DOI:10.1080/09553000903072470.
[13] Ogata T, Teshima T, Kagawa K, et al.Particle irradiation suppresses metastatic potential of cancer cells[J].Cancer Res, 2005, 65(1):113-120.
[14] Cui X, Oonishi K, Tsujii H, et al.Effects of Carbon ion beam on putative colon cancer stem cells and its comparison with x-rays[J].Cancer Res, 2011, 71(10):3676-3687.DOI:10.1158/0008-5472.CAN-10-2926.
[15] Weyrather WK, Ritter S, Scholz M, et al.RBE for carbon track-segment irradiation in cell lines of differing repair capacity[J].Int J Radiat Biol, 1999, 75(11):1357-1364.
[16] 陈万青, 郑荣寿, 张思维, 等.2012年中国恶性肿瘤发病和死亡分析[J].中国肿瘤, 2016, 25(1):1-8.DOI:10.11735/j.issn.1004-0242.2016.01.A001.Chen WQ, Zhen RS, Zhang SW, et al.Report of cancer incidence and mortality in China[J].China Cancer, 2016, 25(1):1-8.
[17] Ferlay J, Shin HR, Bray F, et al.Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].Int J Cancer, 2010, 127(12):2893-2917.DOI:10.1002/ijc.25516.
[18] El-Serag HB.Hepatocellular carcinoma[J].N Engl J Med, 2011, 365(12):1118-1127.DOI:10.1056/NEJMra1001683.
[19] Zeng ZC, Jiang GL, Wang GM, et al.DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line[J].World J Gastroenterol, 2002, 8(5):797-803.DOI:10.3748/wjg.v8.i5.797.
[20] Liang SX, Zhu XD, Xu ZY, et al.Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma:The risk factors and hepatic radiation tolerance[J].Int J Radiat Oncol Biol Phys, 2006, 65(2):426-434.DOI:10.1016/j.ijrobp.2005.12.031.
[21] Kato H, Tsujii H, Miyamoto T, et al.Results of the first prospective study of Carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis[J].Int J Radiat Oncol Biol Phys, 2004, 59(5):1468-1476.DOI:10.1016/j.ijrobp.2004.01.032.
[22] Chiba T, Tokuuye K, Matsuzaki Y, et al.Proton beam therapy for hepatocellular carcinoma:a retrospective review of 162 patients[J].Clin Cancer Res, 2005, 11(10):3799-3805.DOI:10.1158/1078-0432.CCR-04-1350.
[23] 刘锐锋, 张秋宁, 高力英, 等.重离子(12C6+)束治疗肝脏恶性肿瘤的初步临床结果[J].辐射研究与辐射工艺学报, 2014, 32(1):14-21.Liu RF, Zhang QN, Gao LY.A preliminary clinical efficacy of heavy ion(12C6+) beam for hepatic malignance[J].Radiat Res Radiat Process, 2014, 32(1):14-21.
[24] 韩苏军, 张思维, 陈万青, 等.中国前列腺癌发病现状和流行趋势分析[J].临床肿瘤学杂志, 2013, 18(4):330-334.DOI:10.3969/j.issn.1009-0460.2013.04.009.Han SJ, Zhang SW, Chen WQ, et al.Analysis of the status and trends of prostate cancer incidence in China[J].Chin Clin Oncol, 2013, 18(4):330-334.
[25] Tsujii H, Mizoe JE, Kamada T, et al.Overview of clinical experiences on carbon ion radiotherapy at NIRS[J].Radiother Oncol, 2004, 73 Suppl 2:S41-49.
[26] Okada T, Tsuji H, Kamada T, et al.Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer:from 20 to 16 fractions[J].Int J Radiat Oncol Biol Phys, 2012, 84(4):968-972.DOI:10.1016/j.ijrobp.2012.01.072.
[27] 王佳宁, 耿左军.颅内肿瘤发病规律分析[J].河北医药, 2016, 38(4):505-508.DOI:10.3969/j.issn.1002-7386.2016.04.007.Wang JN, Geng ZJ.Analysis for pathogenesis characteristics of intracranial tumor[J] Hebei Med J, 2016, 38(4):505-508.
[28] Brada M, Pijls-Johannesma M, De Ruysscher D.Proton therapy in clinical practice:current clinical evidence[J].J Clin Oncol, 2007, 25(8):965-970.DOI:10.1200/JCO.2006.10.0131.
[29] Combs SE, Kessel K, Habermehl DA, et al.Proton and Carbon ion radiotherapy for primary brain tumors and tumors of the skull base[J].Acta Oncol(Madr), 2013, 52(7):1504-1509.DOI:10.3109/0284186X.2013.818255.
[30] Rieken S, Habermehl D, Haberer T, et al.Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center(HIT):early treatment results and study concepts[J].Radiat Oncol, 2012, 7(41):1-7.DOI:10.1186/1748-717X-7-41.
[31] Hirasawa N, Tsuji H, Ishikawa H, et al.Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis[J].Int J Radiat Oncol Biol Phys, 2006, 67(2):538-543.DOI:10.1016/j.ijrobp.2006.08.080.
[32] Mizoe JE, Hasegawa A, Jingu K, et al.Results of carbon ion radiotherapy for head and neck cancer[J].Radiother Oncol, 2012, 103(1):32-37.DOI:10.1016/j.radonc.2011.12.013.
[33] Shinoto M, Yamada S, Yasuda S, et al.Phase I trial of preoperative, short-course carbon-ion radiotherapy for patients with resectable pancreatic cancer[J].Cancer, 2013, 119(1):45-51.DOI:10.1002/cncr.27723.

相似文献/References:

[1]张睿凤,张忠新,党旭红,等.重离子生物效应的研究进展[J].国际放射医学核医学杂志,2016,40(4):306.[doi:10.3760/cma.j.issn.1673-4114.2016.04.014]
　Zhang Ruifeng,Zhang Zhongxin,Dang Xuhong,et al.Progress on biological effectiveness of heavy ions[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):306.[doi:10.3760/cma.j.issn.1673-4114.2016.04.014]
[2]董娟聪,刘红艳,党旭红,等.12c重离子与γ射线对人外周血淋巴细胞peng-ebv增殖、细胞周期及凋亡影响的比较[J].国际放射医学核医学杂志,2015,39(5):385.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 007]
　dong juancong,liu hongyan,dang xuhong,et al.effects of 12c heavy ion and γ ray irradiation in cell growth, cell cycle and apoptosis of human peripheral blood lymphocytes[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):385.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 007]

备注/Memo

备注/Memo:
收稿日期:2016-06-29
基金项目:天津市自然科学基金重点项目(16JCZDJC36100);中国医学科学院中央级公益性科研院所基本科研业务费项目(2016ZX310077)
通讯作者:焦玲,Email:jiaoling@irm-cams.ac
更新日期/Last Update: 1900-01-01